PENSION & WEALTH MANAGEMENT ADVISORS, INC.’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-89
Closed -$3.46K 594
2025
Q3
$3.46K Hold
89
﹤0.01% 454
2025
Q2
$2.68K Hold
89
﹤0.01% 420
2025
Q1
$2.54K Sell
89
-167
-65% -$5.28K ﹤0.01% 409
2024
Q4
$8.46K Hold
256
﹤0.01% 376
2024
Q3
$9.56K Hold
256
﹤0.01% 300
2024
Q2
$8.6K Hold
256
﹤0.01% 289
2024
Q1
$9.15K Sell
256
-37
-13% -$1.28K 0.01% 281
2023
Q4
$9.65K Buy
293
+186
+174% +$4.99K 0.01% 251
2023
Q3
$2.91K Hold
107
﹤0.01% 237
2023
Q2
$3.38K Hold
107
﹤0.01% 237
2023
Q1
$2.91K Hold
107
﹤0.01% 265
2022
Q4
$3.25K Buy
+107
New +$3.22K ﹤0.01% 230

Other funds holding SBIO

PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s SBIO Position: Q4 2025 in Review

PENSION & WEALTH MANAGEMENT ADVISORS, INC. sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q4 2025, closing a stake of 89 shares — an estimated $3.46K sold.

PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in SBIO in Q4 2022 and held it in 12 quarters. The position peaked at $9.65K in Q4 2023. 58 funds tracked by Wall St. Rank hold SBIO as of Q4 2025.

  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. reported no remaining ALPS Medical Breakthroughs ETF position as of Q4 2025 after selling out during the quarter.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. sold 89 ALPS Medical Breakthroughs ETF shares in Q4 2025, an estimated $3.46K.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in ALPS Medical Breakthroughs ETF in Q4 2022 and held it in 12 quarters.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s ALPS Medical Breakthroughs ETF position peaked at $9.65K in Q4 2023.
  • 58 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2025.

Based on PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s 13F filing for Q4 2025, filed 7 Aug 2026.